background
flavonoid
bioactiv
special
plant
metabolit
mainli
occur
differ
glycosid
due
increas
market
demand
variou
biotechnolog
approach
develop
use
escherichia
coli
microbi
catalyst
stereospecif
glycosyl
flavonoid
despit
effort
process
still
display
low
product
rate
titer
render
unsuit
largescal
applic
contribut
expand
previous
develop
vivo
glucosyl
platform
e
coli
w
effici
system
select
galactosyl
rhamnosyl
ration
novel
metabol
engin
strategi
constitut
introduct
altern
sucros
metabol
form
sucros
phosphorylas
cleav
sucros
fructos
glucos
precursor
udpglucos
preserv
intermedi
glycosyl
purpos
metabol
reaction
knockedout
due
pivot
role
udpglucos
overexpress
interconvert
enzym
gale
ensur
format
udpgalactos
udprhamnos
respect
addit
suppli
exogen
fed
quercetin
overexpress
flavonol
galactosyltransferas
rhamnosyltransferas
rhagt
gl
hyperosid
quercetin
gl
quercitrin
quercetin
could
produc
respect
addit
strain
show
activ
toward
promis
dietari
flavonol
like
kaempferol
fisetin
morin
myricetin
conclus
two
e
coli
w
mutant
engin
could
effect
produc
bioactiv
flavonol
glycosid
hyperosid
quercitrin
start
cheap
substrat
sucros
quercetin
novel
fermentationbas
glycosyl
strategi
allow
econom
viabl
product
variou
glycosid
flavonoid
class
plant
secondari
metabolit
chemic
character
backbon
consist
two
phenyl
ring
heterocycl
ring
date
flavonoid
character
variou
plant
classifi
accord
chemic
structur
ie
number
presenc
hydroxyl
group
function
group
modif
variou
subgroup
anthoxanthin
flavanon
flavanonol
recent
year
flavonoid
garner
much
attent
variou
applic
domain
variou
benefici
effect
human
health
attribut
anticanc
antioxid
antiinflammatori
antimicrobi
antivir
effect
final
step
biosynthesi
flavonoid
often
glycosyl
profound
effect
solubl
stabil
bioactiv
exampl
best
studi
flavonol
quercetin
make
daili
flavonoid
intak
predominantli
occur
differ
glycosid
differ
quercetin
glycoform
report
date
vari
pharmacolog
properti
context
hyperosid
quercetin
quercitrin
quercetin
fig
gain
lot
attent
valuabl
product
pharmaceut
industri
eg
power
antioxid
cytoprotect
effect
promis
antivir
agent
block
replic
influenza
viru
inhibit
virus
hepat
b
sar
furthermor
attribut
antiinflammatori
antidepress
apoptot
antifung
activ
render
interest
therapeut
result
steadili
increas
market
demand
date
major
quercetin
glycosid
extract
plant
materi
gener
labori
lowyield
process
requir
mani
purif
step
vitro
plant
cell
cultur
engin
plant
use
overcom
low
yield
improv
product
howev
sinc
metabol
engin
plant
controversi
still
infanc
approach
often
restrict
smallscal
product
although
chemic
synthesi
quercetin
glycosid
proven
feasibl
stereoselect
format
glycosid
linkag
often
hamper
presenc
variou
reactiv
group
requir
mani
protect
deprotect
step
addit
gener
toxic
wast
low
atomeffici
render
product
process
neither
sustain
econom
viabl
result
last
two
decad
enorm
effort
invest
develop
altern
product
method
special
secondari
plant
metabolit
advanc
field
protein
engin
system
synthet
biolog
acceler
effort
transform
model
organ
like
escherichia
coli
saccharomyc
cerevisia
real
microbi
cell
factori
sustain
product
flavonoid
subsequ
strategi
vivo
glycosyl
flavonoid
also
develop
typic
base
overexpress
specif
glycosyltransferas
transfer
sugar
residu
activ
nucleotid
sugar
aglycon
stereoand
regioselect
way
engin
introduct
target
nucleotid
sugar
pathway
way
fig
transform
e
coli
w
sucrosebas
galactosyl
rhamnosyl
platform
metabol
engin
strategi
appli
make
use
sever
gene
delet
indic
red
overexpress
gene
indic
green
ration
split
metabol
appli
wherebi
sucros
divid
sucros
phosphorylas
basp
fructos
use
growth
glucos
activ
precursor
udpglucos
latter
univers
pivot
molecul
format
udpgalactos
udprhamnos
interconvers
catalyz
enzym
gale
respect
ensur
growthcoupl
product
variou
gene
involv
metabol
udpsugar
precursor
knock
shown
red
product
bioactiv
quercetin
glycosid
hyperosid
quercitrin
chosen
evalu
versatil
engin
product
platform
final
introduct
either
glycosyltransferas
rhagt
ensur
effici
galactosyl
rhamnosyl
respect
variou
quercetin
glycosid
alreadi
produc
e
coli
natur
occur
newtonatur
quercetin
howev
despit
engin
effort
report
product
rate
titer
still
milligram
rang
render
microbi
product
host
unsuit
industri
applic
develop
product
process
typic
biphas
bioconvers
process
use
rest
cell
make
difficult
improv
product
rate
furthermor
system
often
entail
expens
growth
media
addit
enzym
induc
make
overal
process
costli
tackl
problem
previous
develop
effici
platform
glucosyl
small
molecul
e
coli
w
metabol
engin
mutant
creat
coupl
product
glucosid
growth
use
sucros
cheap
sustain
carbon
sourc
introduc
sucros
phosphorylas
bifidobacterium
adolescenti
basp
sucros
split
fructos
use
growth
purpos
glucos
use
precursor
udpglucos
udpglc
format
fig
imped
convers
biomass
precursor
sever
endogen
gene
involv
metabol
phosphoglucomutas
pgm
agp
knock
subsequ
effici
channel
toward
udpglc
overexpress
uridylyltransferas
bifidobacterium
bifidum
ugpa
metabol
udpglc
prevent
knock
udpsugar
hydrolas
usha
galactos
operon
galetkm
howev
view
pivot
role
udpglc
product
larg
varieti
udpsugar
glucosyl
system
easili
extend
toward
udpsugar
udpgalactos
udpgal
udprhamnos
udprha
udpglucuron
present
contribut
previous
develop
e
coli
wbase
glucosyl
platform
transform
platform
galactosyl
rhamnosyl
fig
whose
potenti
demonstr
use
galactosyl
rhamnosyl
exogen
fed
quercetin
yield
hyperosid
quercitrin
respect
case
studi
escherichia
coli
w
fastgrow
nonpathogen
strain
toler
osmot
stress
acid
condit
cultur
high
cell
densiti
make
attract
host
industri
ferment
moreov
e
coli
w
abl
grow
sucros
sole
carbon
sourc
emerg
feedstock
product
bioproduct
henc
e
coli
w
select
host
sucrosebas
vivo
glycosyl
prior
product
glycosid
hyperosid
quercitrin
e
coli
w
toxic
aglycon
quercetin
investig
end
wild
type
wt
strain
grown
minim
sucros
medium
contain
differ
concentr
quercetin
gl
specif
growth
rate
h
respect
significantli
differ
p
anova
one
previous
determin
wt
p
p
p
respect
hand
optic
densiti
nm
h
incub
respect
lower
quercetin
ad
p
p
signific
differ
optic
densiti
could
observ
gl
quercetin
p
view
opt
add
gl
quercetin
evalu
potenti
develop
glycosyl
platform
evalu
vivo
glycosyl
potenti
strain
constitut
express
flavonol
petunia
hybrida
flavonol
thaliana
respect
cultur
minim
medium
gl
quercetin
h
tlc
analysi
supernat
cultur
yield
two
new
yellow
product
spot
tlc
spot
obtain
cultur
retent
time
hyperosid
standard
r
f
subsequ
purifi
analyz
nmr
ms
analysi
confirm
product
quercetin
howev
product
spot
obtain
cultur
differ
retent
factor
r
f
quercitrin
standard
r
f
identifi
isoquercitrin
quercetin
oppos
report
wild
type
e
coli
strain
express
rhagt
simultan
produc
quercitrin
quercetin
isoquercitrin
rhamnosid
could
detect
examin
e
coli
w
genom
reveal
gene
cluster
respons
endogen
product
dtdprhamnos
function
altern
rhamnosyldonor
rhagt
e
coli
b
deriv
present
followup
experi
grown
minim
medium
two
differ
concentr
gl
quercetin
growth
glycosid
format
monitor
h
final
titer
c
p
specif
product
q
p
shown
fig
remark
increas
quercetin
concentr
result
two
threefold
increas
product
titer
indic
quercetin
suppli
ratelimit
crucial
effici
vivo
glycosyl
howev
continu
produc
hyperosid
exponenti
phase
also
reflect
rel
high
specif
product
start
accumul
signific
amount
isoquercitrin
end
exponenti
phase
product
start
coincid
reduct
specif
growth
rate
drop
h
describ
detail
background
section
previous
metabol
engin
e
coli
w
creat
platform
vivo
glucosyl
small
molecul
origin
base
glucosyl
strain
sucros
phosphorylas
encod
basp
locat
mediumcopi
plasmid
transcrib
mediumstrong
constitut
promot
reason
comparison
flexibl
opt
integr
basp
genom
e
coli
w
addit
chromosom
integr
advantag
signific
increas
gene
stabil
sinc
level
gene
express
consider
impact
genom
integr
site
due
structur
differ
supercoil
dna
region
two
differ
dna
site
assess
basp
integr
ie
mela
glgc
encod
adenylyltransferas
respect
end
adapt
knockinknockout
procedur
larg
dna
fragment
appli
schemat
shown
addit
file
figur
basp
control
promot
knock
two
differ
loci
e
coli
w
result
e
coli
w
strain
maxim
specif
growth
rate
max
minim
sucros
medium
shown
fig
compar
origin
strain
pbasp
influenc
knockin
locu
maxim
specif
growth
rate
clear
interestingli
integr
mela
locu
result
strain
max
significantli
differ
refer
strain
pbasp
view
latter
consid
aim
growthcoupl
product
opt
integr
basp
mela
locu
lead
final
product
base
strain
e
coli
w
sglyc
shown
tabl
natur
udpglc
serv
pivot
molecul
format
varieti
udpsugar
exampl
use
interconvert
enzym
udpglucos
gale
udprhamnos
synthas
udpglc
convert
udpgal
udprha
respect
though
gale
nativ
present
e
coli
w
altern
homolog
epimeras
b
bifidum
also
select
clone
due
fig
comparison
specif
glycosid
product
q
p
glycosid
titer
c
p
strain
produc
produc
grown
h
minim
medium
contain
gl
quercetin
error
bar
repres
standard
deviat
tight
complex
regul
gale
express
e
coli
w
hand
udprhamnos
synthesi
restrict
plant
due
lack
rfb
cluster
e
coli
w
even
unabl
form
endogen
dtdprhamnos
altern
rhamnosyl
donor
henc
gene
thaliana
express
plasmid
achiev
udprhamnos
format
e
coli
fig
construct
galactosyl
sgal
rhamnosyl
srha
strain
grown
minim
medium
two
level
gl
quercetin
growth
product
monitor
determin
specif
product
shown
fig
higher
extracellular
quercetin
concentr
result
fivefold
increas
q
p
howev
signific
differ
product
observ
gl
quercetin
indic
udpgalactos
format
effici
gale
homolog
like
rate
limit
step
highest
hyperosid
product
mgg
cdwh
titer
gl
obtain
latter
higher
compar
contrast
tlc
analysi
supernat
cultur
result
product
spot
retent
factor
correspond
quercitrin
confirm
ms
analysi
thu
show
vivo
activ
quercitrin
titer
gl
specif
product
mgg
cdwh
obtain
h
incub
gl
quercetin
ad
medium
correspond
convers
also
mgl
isoquercitrin
produc
extracellularli
correspond
quercitrin
isoquercitrin
product
ratio
suggest
prefer
rhagt
udprhamnos
differ
udpsugar
donor
present
possibl
explan
significantli
lower
specif
product
fivefold
decreas
compar
either
higher
metabol
burden
caus
two
plasmid
system
limit
activ
nativ
galu
could
insuffici
adequ
udpglc
format
demonstr
scalabl
develop
bioprocess
strain
cultur
bioreactor
also
ensur
constant
ph
set
avoid
oxygen
limit
detail
overview
consumpt
sucros
growth
hyperosid
product
given
fig
lagphas
strain
display
growth
rate
h
simultan
produc
hyperosid
observ
specif
product
mgg
cdwh
compar
one
obtain
shake
flask
scale
nearli
quercetin
convert
hyperosid
format
slow
explain
either
observ
correl
quercetin
concentr
q
p
report
revers
like
improv
titer
product
realiz
optim
suppli
quercetin
use
fedbatch
system
best
knowledg
result
obtain
studi
engin
sgal
srha
strain
product
hyperosid
quercitrin
highest
report
date
term
titer
product
rate
maxim
product
rate
obtain
contribut
higher
compar
maxim
product
rate
r
p
max
process
report
literatur
illustr
fig
increas
perform
term
titer
product
obtain
develop
platform
attribut
use
split
metabol
combin
optim
rerout
flux
glucos
toward
udpgalactos
udprhamnos
undesir
convers
activ
sugar
biomass
fig
effect
chromosom
integr
locu
knockin
basp
growth
rate
strain
grown
shake
flask
result
maxim
growth
rate
max
compar
e
coli
w
plasmidbas
basp
express
pbasp
error
bar
repres
standard
deviat
imped
gene
delet
guarante
high
product
yield
addit
sinc
biomass
format
fuel
fructos
moieti
sucros
glycosid
synthesi
go
hand
hand
subsequ
perform
time
high
rate
high
product
equal
guarante
onestep
ferment
process
besid
quercetin
also
flavonol
kaempferol
fisetin
morin
myricetin
significantli
contribut
daili
flavonoid
intak
also
extrem
divers
benefici
effect
sugar
moieti
major
determin
intestin
absorpt
dietari
flavonoid
subsequ
bioactiv
end
strain
grown
tube
ml
minim
medium
contain
gl
either
kaempferol
myricetin
morin
fisetin
growth
product
monitor
h
variou
spot
observ
tlc
similar
retent
factor
hyperosid
quercitrin
mass
spectrometri
use
identifi
compound
produc
confirm
vivo
galactosyl
myricetin
kaempferol
morin
fisetin
tabl
compound
occur
mz
due
complex
trifluoroacet
acid
mobil
phase
galactosid
morin
produc
slow
rate
accord
low
vitro
activ
toward
flavonol
possibl
explan
limit
activ
may
presenc
unusu
hydroxyl
group
posit
may
steric
hinder
deproton
consequ
galactosyl
morin
hydroxyl
group
incub
differ
flavonol
investig
show
two
distinct
glycosid
spot
tlc
correspond
kaempferol
prove
best
substrat
rhagt
predominantli
rhamnosyl
ratio
titer
exceed
mgl
twofold
higher
previous
report
fisetin
hand
effici
glucosyl
yet
format
rhamnosid
effici
titer
mgl
similar
prefer
toward
glucosid
format
also
observ
myricetin
morin
indic
posit
hydroxyl
group
determin
factor
glycosyl
rhagt
product
desir
rhamnosid
galactosid
glucosid
may
improv
consider
use
ugt
specif
toward
certain
flavonol
udpsugar
transform
correspond
ugt
develop
vivo
glycosyl
strain
present
promis
altern
largescal
product
variou
flavonol
glycoform
date
mainli
extract
plant
materi
hand
due
pivot
role
udpglc
variou
udpsugar
form
vivo
eg
udpglucuron
udpxylos
udparabinos
combin
modular
develop
glycosyl
platform
permit
rapid
introduct
ugt
udpsugar
pathway
virtual
glycosid
produc
henc
demonstr
propos
microbi
platform
robust
versatil
effici
microbi
cell
factori
glycosyl
eg
glucosyl
rhamnosyl
galactosyl
small
molecul
although
obtain
product
highest
report
today
compet
current
product
process
improv
limit
due
solubl
issu
aglycon
glycosid
end
followup
research
focu
metabol
engin
eg
introduct
aglycon
pathway
allow
vivo
gradual
product
aglycon
process
optim
eg
bilay
ferment
enabl
situ
recoveri
improv
issu
contribut
biotechnolog
platform
develop
galactosyl
rhamnosyl
small
molecul
secondari
metabolit
natur
product
start
previous
creat
glucosyl
host
end
rout
convert
udpglucos
udpgalactos
udprhamnos
introduc
express
udpglucos
epimeras
gale
udprhamnos
synthas
respect
proof
concept
bioactiv
flavonol
quercetin
select
galactosyl
rhamnosyl
yield
hyperosid
quercetin
quercitrin
quercetin
respect
next
flavonol
petunia
hybrida
flavonol
arabidopsi
thaliana
rhagt
overexpress
metabol
engin
e
coli
w
mutant
strain
creat
abl
produc
mgl
hyperosid
mgl
quercitrin
specif
product
rate
mgg
cdwh
mgg
cdwh
respect
highest
report
date
interestingli
gt
show
vivo
activ
toward
dietari
flavonol
wherebi
exampl
mgl
kaempferol
could
form
extracellularli
plasmid
use
construct
use
gibson
assembl
cliva
pcr
fragment
amplifi
use
polymeras
new
england
biolab
ipswich
massachusett
oligonucleotid
purchas
idt
leuven
belgium
plasmid
bacteri
strain
use
studi
list
tabl
list
primer
creation
gene
knockoutsknockin
clone
express
plasmid
given
addit
file
tabl
e
coli
use
plasmid
clone
propag
e
coli
w
use
express
product
plasmid
creation
gene
knockout
knockin
hyperosid
quercitrin
isoquercitrin
kaempferol
myricetin
purchas
carbosynth
berkshir
uk
chemic
use
purchas
sigma
aldrich
germani
unless
otherwis
indic
express
plasmid
prod
uction
hyperosid
quercitrin
construct
depict
addit
file
figur
figur
gale
genbank
genbank
sequenc
amplifi
genom
dna
e
coli
bifidobacterium
bifidum
respect
cliva
assembl
result
intermediari
plasmid
figur
subsequ
use
amplif
ugpa
backbon
gibson
assembl
gale
insert
backbon
result
final
galactosyl
plasmid
ugpa
respect
figur
similarli
rhagt
introduc
use
gibson
assembl
figur
result
final
rhamnosyl
plasmid
overal
e
coli
w
knockout
mutant
creat
use
one
step
delet
system
datsenko
wanner
strategi
chromosom
integr
basp
control
constitut
promot
flank
mela
glgc
loci
depict
explain
addit
file
figur
transform
plate
minim
sucros
medium
agar
plate
grown
overnight
screen
inhous
strain
e
coli
w
use
chromosom
integr
mela
site
yield
base
strain
sglyc
tabl
strain
e
coli
w
wild
type
transform
product
plasmid
describ
result
galactosyl
sgal
rhamnosyl
srha
strain
given
tabl
composit
lb
minim
sucros
medium
describ
previous
minim
medium
agar
plate
sucros
gl
composit
minim
sucros
medium
contain
addit
gl
agaros
agaros
salt
autoclav
separ
min
sucros
filter
steril
corn
filter
fisher
belgium
heat
min
microwav
oven
w
prior
mix
warm
agaros
salt
solut
mll
miner
solut
steril
ad
prior
pour
plate
escherichia
coli
w
mutant
precultur
grown
ml
lb
medium
antibiot
kanamycin
carbenicillin
requir
mainten
select
plasmid
cultur
grown
h
rpm
use
inocul
ml
minim
sucros
medium
ml
shake
flask
product
hyperosid
quercitrin
quercetin
ad
minim
medium
concentr
gl
growth
condit
previous
describ
sampl
taken
regular
interv
broth
centrifug
supernat
use
analysi
quantif
sugar
analysi
quercetin
glycosid
cultur
collect
extract
ethyl
acet
organ
layer
collect
evapor
speedvac
vacuum
concentr
thermo
fisher
usa
dissolv
dmso
hplc
quantif
bioreactor
setup
ferment
condit
use
previous
describ
product
experi
perform
minim
sucros
medium
without
mop
buffer
addit
quercetin
acceptor
cultur
sampl
primarili
analyz
tlc
silica
gel
f
precoat
plate
merck
germani
plate
run
close
tlc
chamber
develop
use
standard
visual
techniqu
agent
uv
fluoresc
nm
stain
vv
h
subsequ
char
mobil
phase
detect
variou
flavonol
correspond
glycosid
consist
ethyl
acet
acet
acid
formic
acid
water
vv
mixtur
product
spot
intens
flavonol
glycosid
process
quantifi
use
imagej
hplc
quantif
sucros
fructos
glucos
perform
use
xbridg
amid
column
water
usa
describ
previous
quercetin
hyperosid
quercitrin
isoquercitrin
detect
method
describ
pandey
et
al
use
varian
hplc
system
agil
technolog
california
mass
spectrometri
determin
variou
flavonol
glycosid
perform
micromass
quattro
lc
mckinley
scientif
usa
detect
perform
neg
mode
ms
capillari
voltag
kv
cone
voltag
v
cone
desolv
ga
flow
lh
sourc
cone
temperatur
respect
quercetin
glycosid
extract
broth
equal
volum
ethyl
acet
organ
layer
evapor
dryness
remain
product
dissolv
solvent
system
describ
run
prepar
tlc
plate
band
contain
hyperosid
r
f
quercitrin
r
f
scrape
extract
ethyl
acet
evapor
yield
bright
yellow
powder
product
confirm
nmr
spectra
report
elsewher
